Cancer

RSS

CRL-8256, with potential in cancer chemotherapy, emerges from joint French and Belgian research

Oct. 10, 2000

Coulter's Bexxar assigned priority review status by FDA

Oct. 10, 2000

Myriad reports location of prostate cancer susceptibility gene

Oct. 10, 2000

Clinical trial results for IL-2/SEB combination therapy for melanoma positive

Oct. 10, 2000

Potent topoisomerase inhibitors related to camptothecin described in recent patent

Oct. 6, 2000

Dihydroquinazoline antitumor agents with folate-independent mechanism described by CRC

Oct. 6, 2000

Series of microtubule-stabilizing epothilone derivatives jointly developed by BMS and GBF

Oct. 6, 2000

Kinase inhibitors and their use in the treatment of cancer, psoriasis and osteoporosis

Oct. 6, 2000

DTI-015 phase I/II clinical trials begin enrollment for treatment of glioblastoma multiforme

Oct. 6, 2000

NeoRx's skeletal targeted radiotherapy progresses to phase III

Oct. 6, 2000